(R)-1-(5-Chloro-2-(2-(4-(4-fluorobenzyl)-2-methylpiperazin-1-yl)-2-oxoethoxy)phenyl)urea hydrochloride, 98%, 10mg

(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 97%, 1g

3-Bromo-1-triisopropylsilyl pyrrole, 97%, 1g

(3-Chloro-2-methoxypyridin-4-yl)methanol, 97%, 5g

5-Bromo-1H-indazol-6-ol, 95.0%, 250mg

Ethyl 6-(aminomethyl)picolinate, 95.0%, 250mg

APIGENIN-7-GLUCOSIDE, 98%, 50mg

iScope IS.1159-PLPHi Biocular para contraste de fases con objetivos IOS de fase Plan, mesa cruzada sin bastidor y accesorio para fotografías (infinito - cabezal basculante ergonómico)

2,5-DIOXOPYRROLIDIN-1-YL 1-(2,5-DIOXO-2,5-DIHYDRO-1H-PYRROL-1-YL)-3-OXO-7,10,13,16,19,22,25,28,31,34-DECAOXA-4-AZAHEPTATRIACONTAN-37-OATE, 95%, 250mg

Benzyl 2-Aminobenzoate>98.0%(GC)(T)5g

3-Fluoro-5-(trifluoromethyl)phenol, 98.0%, 100g

3-Ethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine, 95.0%, 25g

Z-Lys(Boc)-OH, 98%, 1g